Загрузка...
Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients
Background: Sildenafil, a phosphodiestase type 5 inhibitor, was approved in 2005 for the treatment of pulmonary arterial hypertension (PAH) in adults and is commonly used off-label for pediatric patients. Little is known, however, about sildenafil’s side effects in this population. Methods: Single i...
Сохранить в:
| Опубликовано в: : | Front Pediatr |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4353247/ https://ncbi.nlm.nih.gov/pubmed/25806361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2015.00012 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|